53 related articles for article (PubMed ID: 32111808)
1. Clinical significance of IL-37 serum level and polymorphism in patients with endometrial cancer.
Haghshenas MR; Shiravani Z; Samare-Najaf M; Khansalar S; Razavinasab SA; Ghaderi A; Jamali N
Eur Cytokine Netw; 2023 Dec; 34(4):63-69. PubMed ID: 38526176
[TBL] [Abstract][Full Text] [Related]
2. 3'UTR-CDKN2A and CDK4 Germline Variants Are Associated With Susceptibility to Cutaneous Melanoma.
Tovar-Parra D; Gil-Quiñones SR; Nova J; Gutiérrez-Castañeda LD
In Vivo; 2021; 35(3):1529-1536. PubMed ID: 33910831
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological Significance and Potential Drug Target of CDKN2A/p16 in Endometrial Carcinoma.
Su L; Wang H; Miao J; Liang Y
Sci Rep; 2015 Aug; 5():13238. PubMed ID: 26283007
[TBL] [Abstract][Full Text] [Related]
4. Association of SNPs in CDKN2A (P14ARF) Tumour Suppressor Gene With Endometrial Cancer in Postmenopausal Women.
Wujcicka W; Zajac A; Szyllo K; Smolarz B; Romanowicz H; Stachowiak G
In Vivo; 2020; 34(2):943-951. PubMed ID: 32111808
[TBL] [Abstract][Full Text] [Related]
5. p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck.
Zhang Y; Sturgis EM; Zafereo ME; Wei Q; Li G
Cancer; 2011 Mar; 117(6):1227-35. PubMed ID: 21381012
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of codon 72 of the TP53 gene in endometrial carcinoma of postmenopausal women.
Zając A; Stachowiak G; Smolarz B; Wilczyński JR
Postepy Hig Med Dosw (Online); 2013 Dec; 67():1312-8. PubMed ID: 24379271
[TBL] [Abstract][Full Text] [Related]
7. 135G>C and 172G>T polymorphism in the 5' untranslated region of RAD51 and sporadic endometrial cancer risk in Polish women.
Smolarz B; Samulak D; Michalska M; Góralczyk B; Szyłło K; Lewy J; Sporny S; Kokołaszwili G; Burzyński M; Romanowicz-Makowska H
Pol J Pathol; 2011 Sep; 62(3):157-62. PubMed ID: 22102073
[TBL] [Abstract][Full Text] [Related]
8. HSD17B1 gene polymorphisms and risk of endometrial and breast cancer.
Setiawan VW; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
Cancer Epidemiol Biomarkers Prev; 2004 Feb; 13(2):213-9. PubMed ID: 14973105
[TBL] [Abstract][Full Text] [Related]
9. Impact of
Wujcicka W; Zając A; Stachowiak G
In Vivo; 2019; 33(3):917-924. PubMed ID: 31028217
[TBL] [Abstract][Full Text] [Related]
10. Aberrant Expression of p14
Inoue K; Fry EA
Tumor Microenviron; 2018; 1(2):37-44. PubMed ID: 30740529
[TBL] [Abstract][Full Text] [Related]
11. Inactivation of Tp53 and Pten drives rapid development of pleural and peritoneal malignant mesotheliomas.
Sementino E; Menges CW; Kadariya Y; Peri S; Xu J; Liu Z; Wilkes RG; Cai KQ; Rauscher FJ; Klein-Szanto AJ; Testa JR
J Cell Physiol; 2018 Nov; 233(11):8952-8961. PubMed ID: 29904909
[TBL] [Abstract][Full Text] [Related]
12. Regulatory Network of ARF in Cancer Development.
Ko A; Han SY; Song J
Mol Cells; 2018 May; 41(5):381-389. PubMed ID: 29665672
[TBL] [Abstract][Full Text] [Related]
13. Association of the independent polymorphisms in CDKN2A with susceptibility of acute lymphoblastic leukemia.
Zhou X; Liao F; Zhang J; Qin Y; Xu H; Ding Z; Zhang Y; Zhang F
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29654170
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
